FDA Orange Book · active-ingredient family
Duloxetine hydrochloride
Duloxetine hydrochloride is approved as 3 brand and 23 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DULOXETINE HYDROCHLORIDE · NDA 219131
3
Brand (NDA)
23
Generics (ANDA)
5
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, delayed rel pellets
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DULOXETINE HYDROCHLORIDERLD×3 | ALMATICA | NDA 219131 | — | Feb 27, 2026 | |
| DRIZALMA SPRINKLERLD×4 | SUN PHARM | NDA 212516 | — | Jul 19, 2019 | |
| CYMBALTARLD×3 | LILLY | NDA 021427 | — | Aug 03, 2004 |
Generic (ANDA) products (23)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DULOXETINE HYDROCHLORIDE×3 | SUNSHINE | ANDA 212328 | AB | Feb 11, 2021 | |
| DULOXETINE HYDROCHLORIDE×3 | YAOPHARMA CO LTD | ANDA 207219 | — | Aug 16, 2019 | |
| DULOXETINE HYDROCHLORIDE×3 | QINGDAO BAHEAL PHARM | ANDA 210599 | AB | Apr 17, 2019 | |
| DULOXETINE HYDROCHLORIDE×3 | CSPC OUYI | ANDA 211310 | AB | Oct 16, 2018 | |
| DULOXETINE HYDROCHLORIDE×3 | PRINSTON INC | ANDA 206653 | AB | May 18, 2017 | |
| DULOXETINE HYDROCHLORIDE×3 | MACLEODS PHARMS LTD | ANDA 204815 | AB | Mar 23, 2017 | |
| DULOXETINE HYDROCHLORIDE×4 | AJANTA PHARMA LTD | ANDA 208706 | AB | Jan 06, 2017 | |
| DULOXETINE HYDROCHLORIDE×3 | HETERO LABS LTD III | ANDA 204343 | AB | Aug 03, 2016 | |
| DULOXETINE HYDROCHLORIDE×3 | INVENTIA | ANDA 202336 | AB | Oct 28, 2015 | |
| DULOXETINE HYDROCHLORIDE×3 | PH HEALTH | ANDA 090780 | — | Oct 28, 2015 | |
| DULOXETINE HYDROCHLORIDE×3 | ALKEM LABS LTD | ANDA 203197 | AB | Aug 26, 2015 | |
| DULOXETINE HYDROCHLORIDE×3 | APOTEX | ANDA 202045 | — | Jun 11, 2014 | |
| DULOXETINE HYDROCHLORIDE×4 | BRECKENRIDGE | ANDA 203088 | AB | Jun 11, 2014 | |
| DULOXETINE HYDROCHLORIDE×3 | ALEMBIC | ANDA 202949 | AB | Jun 09, 2014 | |
| DULOXETINE HYDROCHLORIDE×4 | ZYDUS HLTHCARE | ANDA 090739 | AB | Jan 08, 2014 | |
| DULOXETINE HYDROCHLORIDE×3 | ZYDUS PHARMS | ANDA 090728 | AB | Jan 08, 2014 | |
| DULOXETINE HYDROCHLORIDE×3 | ACTAVIS ELIZABETH | ANDA 090776 | AB | Dec 17, 2013 | |
| DULOXETINE HYDROCHLORIDE×3 | ADAPTIS | ANDA 090723 | — | Dec 11, 2013 | |
| DULOXETINE HYDROCHLORIDE×3 | AUROBINDO PHARMA LTD | ANDA 090778 | AB | Dec 11, 2013 | |
| DULOXETINE HYDROCHLORIDE×4 | LUPIN | ANDA 090694 | AB | Dec 11, 2013 | |
| DULOXETINE HYDROCHLORIDE×3 | SUN PHARM | ANDA 090745 | — | Dec 11, 2013 | |
| DULOXETINE HYDROCHLORIDE×3 | TEVA PHARMS USA | ANDA 090783 | — | Dec 11, 2013 | |
| DULOXETINE HYDROCHLORIDE×3 | TORRENT | ANDA 090774 | — | Dec 11, 2013 |
Listed patents (5)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9839626 | Apr 13, 2037 | in 11 yr | Product |
| 10413525 | Apr 13, 2037 | in 11 yr | Product |
| 12171742 | Apr 13, 2037 | in 11 yr | Product |
| 11202772 | Apr 13, 2037 | in 11 yr | Product |
| 10959982 | Apr 13, 2037 | in 11 yr | Product |
Duloxetine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

